A small molecule inhibits HCV replication and alters NS4B’s subcellular distribution

Hepatitis C Virus (HCV) is a leading cause of liver disease and represents a significant public health challenge. Treatments for this disease are inadequate and improved antiviral therapies are necessary. Several such antivirals are in development, most of which target the well-characterized NS3 pro...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Bryson, Paul D., Cho, Nam-Joon, Einav, Shirit, Lee, Choongho, Tai, Vincent, Bechtel, Jill, Sivaraja, Mohan, Roberts, Chris, Schmitz, Uli, Glenn, Jeffrey S.
Format: Artigo
Langue:Inglês
Publié: 2010
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3909674/
https://ncbi.nlm.nih.gov/pubmed/20363257
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.antiviral.2010.03.013
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires